ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,974, issued on Oct. 6, was assigned to OSAKA UNIVERSITY (Osaka, Japan).

"Composition for use in treating dystrophic epidermolysis bullosa" was invented by Katsuto Tamai (Suita, Japan), Yasushi Kikuchi (Suita, Japan) and Tomoki Tamakoshi (Suita, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a composition for use in the treatment of dystrophic epidermolysis bullosa, comprising a cell obtained from a patient with dystrophic epidermolysis bullosa, wherein the cell is a mesenchymal stem cell and genetically modified to produce type VII collagen. The present disclosure also relates to a composition for use in the tr...